GlassScriptPhysician profile
Arshad P Malik
NPI 1386630325
$3,147.43
in general payments reported to CMS, 2019-2025
44 companies · $246 in 2025
The $246 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,346 · 2020: $148 · 2021: $251 · 2022: $305 · 2023: $430 · 2024: $421 · 2025: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,097.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Incorporated | $404.83 | 2019 | |
| Cook Medical LLC | $396.55 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $376.10 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $182.46 | 2020-2024 | Xarelto |
| Ekos Corporation | $168.33 | 2019 | |
| Cardiovascular Systems INC. | $167.77 | 2019-2022 | |
| Amgen INC. | $149.97 | 2021-2025 | Repatha, Repatha |
| Inspire Medical Systems, INC. | $148.99 | 2023-2024 | Inspire |
| Abbott Laboratories | $115.89 | 2019-2022 | |
| Boston Scientific Corporation | $100.17 | 2024 | Watchman Flx |
| Astellas Pharma US INC | $77.78 | 2019 | |
| Merck Sharp & Dohme LLC | $72.64 | 2021-2023 | Verquvo |
| Endologix LLC | $65.55 | 2023 | Ovation Ix Iliac Stent Graft |
| Scpharmaceuticals INC. | $53.89 | 2024-2025 | |
| Itamar Medical INC | $51.91 | 2023 | Watchpatone |
Show all 37 companies
7 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arshad Malik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.